Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy and recurrent abortion: a randomized clinical trial

M T Illeni1, G Marelli, F Parazzini

  • 1Servizio di Immunoematologia, Istituto Nazionale Tumori, Milan, Italy.

Human Reproduction (Oxford, England)
|July 1, 1994
PubMed
Summary

Paternal leukocyte immunotherapy did not significantly improve pregnancy outcomes for women with unexplained recurrent abortions compared to expectant management. Further research is needed to establish effective treatments for recurrent pregnancy loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serial cervical-length measurements after first episode of threatened preterm labor improve prediction of spontaneous delivery prior to 37 weeks' gestation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

The effect of delayed umbilical cord clamping on cord blood gas analysis in vaginal and caesarean-delivered term newborns without fetal distress: a prospective observational study.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Iatrogenic late preterm birth: when is it recommended? A Delphi survey promoted by the Italian Society of Perinatal Medicine.

European journal of obstetrics, gynecology, and reproductive biology·2019
Same author

Mediterranean diet and the risk of poor semen quality: cross-sectional analysis of men referring to an Italian Fertility Clinic.

Andrology·2019
Same author

Alcohol intake and semen variables: cross-sectional analysis of a prospective cohort study of men referring to an Italian Fertility Clinic.

Andrology·2018

Area of Science:

  • Reproductive Immunology
  • Obstetrics and Gynecology
  • Clinical Trials

Background:

  • Unexplained recurrent abortion affects numerous women, impacting reproductive success.
  • Current treatment options for unexplained recurrent abortion are limited and often ineffective.
  • Immunotherapy with paternal leukocytes has been proposed as a potential intervention.

Purpose of the Study:

  • To compare the efficacy of immunotherapy with paternal leukocytes against expectant management in improving obstetric outcomes for women with unexplained recurrent abortion.
  • To assess the cumulative pregnancy rates and spontaneous abortion rates in both treatment groups.

Main Methods:

  • A randomized controlled trial was conducted involving 44 women with unexplained recurrent abortion.
  • Participants were allocated to either immunotherapy with purified paternal lymphocytes or expectant management.

Related Experiment Videos

  • Eligibility criteria included a history of three or more miscarriages, negative immunological screening, and no mixed lymphocyte culture inhibition.

    • Main Results:

    • Pregnancy rates over 4 years were 37% for immunotherapy and 45% for expectant management, a difference that was not statistically significant.
    • In the immunotherapy group, 6 out of 16 pregnancies resulted in spontaneous abortion.
    • In the expectant management group, 2 out of 14 pregnancies resulted in spontaneous abortion, with one late fetal death.

    Conclusions:

    • Paternal leukocyte immunotherapy did not demonstrate a significant benefit over expectant management for improving obstetric outcomes in women with unexplained recurrent abortion.
    • No adverse effects were reported in women receiving immunotherapy.
    • The study suggests that expectant management may be as effective as immunotherapy for this patient population, warranting further investigation into alternative treatments.